Brand VerifiedGermany

Evonik Industries AG

Evonik

Evonik is a German specialty chemicals powerhouse headquartered in Essen, Germany. Formed in 2007 with a century-old industrial heritage, the company generated €14.07 billion in 2025 revenue. Its Care division contributed €1.81 billion, specializing in high-purity ceramides, amino acids, and advanced delivery systems. Evonik employs 31,053 people across 100+ production sites in 27 countries. Evonik ranks #3 globally on SpecialChem's cosmetic ingredient supplier popularity index, renowned for its ceramide and lipid nanoparticle technologies.

Strengths:
• World leader in synthetic ceramides and sphingolipids for skincare
• pioneering lipid nanoparticle (LNP) delivery technology
• strong free cash flow of €695 million with 37% cash conversion rate
• diverse industrial base spanning 27-country manufacturing network
• deep expertise in active delivery systems bridging pharma and cosmetics.
Weaknesses:
• Exposure to global chemical destocking cycles affecting base care ingredients
• intense price competition in standard surfactant categories
• complex organizational structure following 2025 financial restructuring
• significant energy cost exposure in European manufacturing operations.

Business Nature

Evonik Industries AG operates over 100 production sites across 27 countries with a specialty chemical manufacturing model focused on high-barrier-to-entry segments. In cosmetic ingredients, Evonik's Care Solutions division runs dedicated facilities for synthetic ceramides, sphingolipids, and lipid nanoparticle LNP technology platforms at its Essen, Hanau, and Shanghai sites. The company's manufacturing philosophy emphasizes in-house control from raw material quality assurance through to finished specialty active delivery systems, supported by proprietary process technology including membrane-based separations and continuous flow chemistry for cosmetic-grade surfactants and emulsifiers.

Core Business Areas

Surfactants & Cleansers — Core Business
• Specialty amphoteric and nonionic surfactants for mild cleansing systems
• Sugar-based surfactants with excellent environmental profiles
• High-performance emulsifier systems for complex formulations

Base Cosmetic Formulation Materials — Core Business
• High-purity emollients and ester oils with optimized sensory properties
• Silicone alternatives derived from renewable feedstocks
• Encapsulation matrices for active ingredient stabilization

Functional Additives — Core Business
• SK-INFLUX biomimetic ceramide complexes for skin barrier repair
• Amino acid-based moisturizing factors NMF for hydration
• Lipid nanoparticles LNP for advanced active delivery systems

Polymeric Rheology Modifiers & Silicone Elastomers — Core Business
• Cross-linked silicone elastomer gels for sensory modification
• Polymeric thickeners and suspension aids for personal care
• Bio-based rheology modifiers from renewable sources

Industry Rankings

4Top 10 Cosmetic Ingredients & Care Manufacturers & Suppliers

Mfr

4Top 10 Cosmetic Ingredients & Care Companies

Brand

4Top 10 Pharmaceutical Raw Materials & Excipients Manufacturers & Suppliers

Mfr

5Top 10 Pharmaceutical Raw Materials & Excipients Companies

Brand

Corporate Report

Evonik Industries AG is a German specialty chemicals company headquartered in Essen, North Rhine-Westphalia. With 2025 revenue of €14.07 billion and 31,053 employees across 100+ production sites in 27 countries, Evonik is a global leader in high-value cosmetic active ingredients and delivery systems.

Business Overview

Evonik has established itself as the third most popular cosmetic ingredient supplier globally on SpecialChem's ranking, driven by its exceptional portfolio of ceramides, amino acids, and active delivery technologies. The company's Care division, part of the Custom Solutions segment, generated €1.81 billion in 2025 sales, maintaining strong profitability through premium product pricing. Evonik's competitive advantage lies in its ability to bridge pharmaceutical-grade precision with cosmetic-scale manufacturing.

The company's SK-INFLUX ceramide platform has become an industry standard for skin barrier repair formulations, used by leading global skincare brands. Evonik's lipid nanoparticle technology, originally developed for mRNA vaccine delivery, is now being adapted for cosmetic active ingredient delivery, creating a unique technological bridge between pharma and personal care. The company operates on a Local-for-Local production model with manufacturing facilities distributed across 27 countries.

Key Strengths

• Global market leader in synthetic ceramides for skincare applications
• Pioneering lipid nanoparticle technology adapted from pharmaceutical delivery systems
• Strong free cash flow of €695 million demonstrating financial discipline
• Diversified manufacturing footprint across 27 countries providing supply chain resilience
• Ranked #3 globally on SpecialChem cosmetic ingredient supplier index

Challenges & Outlook

Evonik faces headwinds from the global chemical destocking cycle, which has pressured standard surfactant and emollient volumes. The company's complex organizational structure, undergoing a major financial restructuring in 2025, adds execution risk. European energy costs remain a persistent challenge for its domestic manufacturing base, though the company's extensive global production network provides meaningful mitigation.

VerityRank Score: 89/100

VerityRank Score

89/ 100

Based on market presence, financial scale, operational capacity, and brand strength.

Quick Facts

Headquarters

Essen, North Rhine-Westphalia, Germany

Founded

2007

Employees

31,053

Factories

100+ production sites across 27 countries

Listing

Listed on Frankfurt Stock Exchange

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website , Evonik Q4 2025 Reporting
Evonik Financial & Sustainability Report 2025
Evonik Health Care Business

Back to Rankings